Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pfizer Decides Not To Challenge AbbVie's Humira Biosimilar Patents

Adalimumab monoclonal antibody drug. Anti-inflammatory TNF-alpha inhibitor used in treatment of rheumatoid arthritis, psoriasis, ulcerative colitis, etc. Generic name and stylized antibody.

Additional Topics

United States Biosimilars Commercial Legal Issues Policy BioPharmaceutical

More from Biosimilars

More from Biosimilars & Generics

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window